Klh. Carpenter et al., MACROPHAGES, LIPID OXIDATION, CEROID ACCUMULATION AND ALPHA-TOCOPHEROL DEPLETION IN HUMAN ATHEROSCLEROTIC LESIONS, Gerontology, 41, 1995, pp. 53-64
Necropsy samples of atherosclerotic lesions of different histological
stages have been analysed. Ceroid was present in all the lesions, with
in lipid-laden macrophage foam cells and extracellularly in the athero
matous core of advanced lesions. Mean levels of 7 beta-hydroxycholeste
rol, 26-hydrbxycholesterol and hydroxyoctadecadienoic acids were all s
ignificantly greater in lesions than in normal intima. Levels of hydro
xycholesterols were very low or undetectable in normal intima. Fatty s
treaks showed the highest ratio of 7 beta-hydroxycholesterol to choles
terol, and the lowest ratio of linoleate to oleate, suggesting that th
is type of lesion experiences the greatest free radical activity. Leve
ls of 26-hydroxycholestrol, a product of the cytochrome P-450 enzyme s
terol 26-hydroxylase, and the ratio of 26-hydroxycholesterol to choles
terol were significantly higher in advanced lesions than in intermedia
te lesions or fatty streaks. The ratio of alpha-tocopherol to choleste
rol levels varied widely in normal intima but was consistently low in
lesions, especially those rich in macrophage foam cells, suggesting th
at oxidative activity in the lesion may lead to significant oxidation
of the lesion constituents only after alpha-tocopherol has been deplet
ed. Macrophage death was a characteristic feature of advanced lesions,
with apoptotic bodies present, and occasionally, intact apoptotic cel
ls were seen in lesions. These striking correlations between macrophag
es, lipid oxidation, alpha-tocopherol depletion, ceroid accumulation,
and macrophage death in advanced lesions, strongly support a role for
oxidative damage in atherosclerosis, and lend credence to the idea tha
t alpha-tocopherol dietary supplementation may slow the progression of
atherosclerosis in humans.